| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/15/2000 | WO2000012547A3 Benzodiazepines and benzothiazepines derivatives and hbsag peptides binding to annexins, their compositions and use |
| 06/15/2000 | WO2000011151A3 Direct oviduct transgenesis |
| 06/15/2000 | WO2000010598A3 Recombinant botulinium toxin for the treatment of mucus hypersecretion |
| 06/15/2000 | WO2000009711A3 ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE α1/β1 (hsGCα1/β1) |
| 06/15/2000 | WO2000009693A3 Identification of the gene causing the mouse scurfy phenotype and its human ortholog |
| 06/15/2000 | WO2000009654A3 Profiling and cataloging expressed protein tags |
| 06/15/2000 | WO2000009074A3 Variable output applicator and method for multi-component biologic fluid agents, and application method |
| 06/15/2000 | WO2000008143A3 Gene isolated on the short arm of human chromosome 17 |
| 06/15/2000 | WO2000006732A9 Polynucleotide encoding an autoantigen associated with endometriosis |
| 06/15/2000 | WO2000006726A3 Delta-related polypeptides |
| 06/15/2000 | WO2000005378A3 Streptococcus suis vaccines and diagnostic tests |
| 06/15/2000 | WO2000005374A3 Molecules associated with cell proliferation |
| 06/15/2000 | WO2000005369A3 Nucleotide sequences and amino acid sequences of secreted proteins involved in angiogenesis |
| 06/15/2000 | WO2000005366A3 Xiap ires and uses thereof |
| 06/15/2000 | WO2000005254A3 Novel peptides for use in immunotherapy of autoimmune diseases |
| 06/15/2000 | WO2000005253A3 Antagonists specific for the corticotropin-releasing factor receptor type 2 (crfr2) |
| 06/15/2000 | WO2000004154A3 Genes encoding sulfate assimilation proteins |
| 06/15/2000 | WO2000003018A3 Antibiotic protein and method of production |
| 06/15/2000 | WO2000003011A3 METHOD FOR PRODUCING A PEPTIDE WITH A pI ABOVE 8 OR BELOW 5 |
| 06/15/2000 | WO2000001821A3 Neurotransmission associated proteins |
| 06/15/2000 | WO1999067386A3 Differentially expressed genes in pancreatic cancer and displasia |
| 06/15/2000 | WO1999064592A3 Green fluorescent proteins for measuring the ph of a biological sample |
| 06/15/2000 | WO1999063054A3 Mutant forms of the al2 gene of geminiviruses |
| 06/15/2000 | WO1999061452A3 acpS |
| 06/15/2000 | WO1999061052A9 Oral immunization with papillomavirus virus-like particles |
| 06/15/2000 | WO1999060021A3 Use of activated t cells, nervous system-specific antigens for treating disorders of the nevrous system |
| 06/15/2000 | WO1999058098A3 HUMAN ANTITHROMBIN IIIs AND METHODS RELATED THERETO |
| 06/15/2000 | WO1999055858A3 Human nucleic acid sequences obtained from pancreas tumor tissue |
| 06/15/2000 | WO1999047669A3 Human nucleic acid sequences from tissue of breast tumors |
| 06/15/2000 | WO1999029724A3 Dna encoding pasteurella multocida outer membrane protein |
| 06/15/2000 | WO1999014328A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/15/2000 | WO1999002550A8 Ctl epitopes from ebv |
| 06/15/2000 | DE19903371C1 A mammal with inducible in situ ductal carcinoma useful as a model for research and identification of therapeutics |
| 06/15/2000 | DE19856066A1 A novel metabotropic receptor complex from the central nervous system, related coding sequences and methods of identifying binding substances, ligands and interactions with other proteins |
| 06/15/2000 | CA2778047A1 Analogues of glp-1 |
| 06/15/2000 | CA2768016A1 Glp-1 analogues |
| 06/15/2000 | CA2746535A1 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 06/15/2000 | CA2678259A1 A recombinant vector expressing multiple costimulatory molecules and uses thereof |
| 06/15/2000 | CA2354644A1 Muc-1 antagonists and methods of treating immune disorders |
| 06/15/2000 | CA2354612A1 Tumor necrosis factor receptor homologue-1 ("trh1") |
| 06/15/2000 | CA2354374A1 Live attenuated venezuelan equine encephalitis vaccine |
| 06/15/2000 | CA2354232A1 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 06/15/2000 | CA2354190A1 Polypeptides and polynucleotides "basb040" from neisseria meningitidis and vaccine comprising said polypeptides and polynucleotides |
| 06/15/2000 | CA2354189A1 Methods of inhibiting ectopic calcification |
| 06/15/2000 | CA2354142A1 Reversible aqueous ph sensitive lipidizing reagents, compositions and methods of use |
| 06/15/2000 | CA2354044A1 Protein transduction system and methods of use thereof |
| 06/15/2000 | CA2354028A1 Neisseria meningitidis basb041 polypeptides and encoding polynucleotides and uses thereof |
| 06/15/2000 | CA2353797A1 Neuron-associated proteins |
| 06/15/2000 | CA2353776A1 Composition and method for regulation of body weight and associated conditions |
| 06/15/2000 | CA2353559A1 Facs assisted methods for introducing individual chromosomes into cells |
| 06/15/2000 | CA2353525A1 Drug targets in candida albicans |
| 06/15/2000 | CA2352740A1 Procollagen c-proteinase inhibitors |
| 06/15/2000 | CA2352608A1 Heat shock genes and proteins from neisseria meningitidis, candida glabrata and aspergillus fumigatus |
| 06/15/2000 | CA2352569A1 Novel g protein-coupled receptor |
| 06/15/2000 | CA2351628A1 Use of trans-activation and cis-activation to modulate the persistence of expression of a transgene |
| 06/15/2000 | CA2351562A1 A method for detecting neuronal cell damage by quantification of map-2 levels in biological fluids |
| 06/15/2000 | CA2351452A1 Methods and compositions useful for targeting activated vitronectin receptor .alpha.v.beta.3 |
| 06/15/2000 | CA2351346A1 Protein scaffolds for antibody mimics and other binding proteins |
| 06/15/2000 | CA2342967A1 Modifying protein immunogenicity |
| 06/14/2000 | EP1008652A1 Vectors based on recombinant defective viral genomes, and their use in the formulation of vaccines |
| 06/14/2000 | EP1008648A1 Gene causative of rheumatoid arthritis, method for the diagnosis of rheumatoid arthritis, and method for the determination of factors causing rheumatoid arthritis |
| 06/14/2000 | EP1008604A1 Cell chemotactic factor (cctf) originating in mammalian tooth precement or cement, method for purifying the same, and novel connective tissue adhesion promoters containing the same as the active ingredient |
| 06/14/2000 | EP1008603A1 Soluble polypeptides |
| 06/14/2000 | EP1008351A1 Carcinostatic agents |
| 06/14/2000 | EP1007970A1 Diagnostic kit for skin tests, and method |
| 06/14/2000 | EP1007964A1 FORMATION AND USE OF PRION PROTEIN (PrP) COMPLEXES |
| 06/14/2000 | EP1007721A1 Process for preparing obesity protein analogs |
| 06/14/2000 | EP1007718A1 Polymerase enhancing factor (pef) extracts, pef protein complexes, isolated pef protein, and methods for purifying and identifying |
| 06/14/2000 | EP1007717A2 Methods and compositions for therapies using genes encoding secreted proteins such as interferon-beta |
| 06/14/2000 | EP1007715A2 Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same |
| 06/14/2000 | EP1007714A1 Regulatory sequences capable of conferring expression of a heterologous dna sequence in endothelial cells in vivo and uses thereof |
| 06/14/2000 | EP1007712A1 The use of mixed duplex oligonucleotides to effect localized genetic changes in plants |
| 06/14/2000 | EP1007711A1 Für drosomycin kodierendes chimäres gen, dieses gen enhaltender vektor und herstellung von krankheitsresistenten transgenen pflanze |
| 06/14/2000 | EP1007710A1 A sunflower albumin 5' regulatory region for the modification of plant seed lipid composition |
| 06/14/2000 | EP1007709A1 Pathogen-induced plant promoters |
| 06/14/2000 | EP1007706A1 Rna binding protein and binding site useful for expression of recombinant molecules |
| 06/14/2000 | EP1007705A1 Sugarcane bacilliform virus promoter |
| 06/14/2000 | EP1007701A1 Resistance mechanisms to ic type r/m bacteriophages of lactic acid bacteria |
| 06/14/2000 | EP1007700A1 Immunological detection of prions |
| 06/14/2000 | EP1007699A1 Peptide-enhanced transfections |
| 06/14/2000 | EP1007698A1 Expression of heterologous proteins |
| 06/14/2000 | EP1007696A1 Il-13 receptor specific chimeric proteins and uses thereof |
| 06/14/2000 | EP1007690A2 Genes encoding enzymes for lignin biosynthesis and uses thereof |
| 06/14/2000 | EP1007688A2 Desaturase antigen of mycobacterium tuberculosis |
| 06/14/2000 | EP1007687A1 Fiv vaccine |
| 06/14/2000 | EP1007686A1 Tuberculosis vaccine |
| 06/14/2000 | EP1007685A2 Surface exposed proteins from chlamydia pneumoniae |
| 06/14/2000 | EP1007684A2 Method and means for modulating plant cell cycle proteins and their use in controlling plant cell growth |
| 06/14/2000 | EP1007683A1 Coffee storage proteins |
| 06/14/2000 | EP1007682A1 Novel nucleic acid molecules and uses therefor |
| 06/14/2000 | EP1007681A1 Method of increasing the iron content of plant cells |
| 06/14/2000 | EP1007679A1 Recombinant human erythropoietin with advantageous glycosylation profile |
| 06/14/2000 | EP1007678A1 Kringle1 |
| 06/14/2000 | EP1007676A1 High affinity immunoglobulin e receptor-like protein |
| 06/14/2000 | EP1007675A1 Porcine mhc class i genes and uses thereof |
| 06/14/2000 | EP1007674A1 Testis-specific transcription factor zgcl-1 |
| 06/14/2000 | EP1007673A1 Novel bone mineralization proteins, dna, vectors, expression systems |
| 06/14/2000 | EP1007672A1 Intracellular glucocorticoid-induced leucine zippers modulators of apoptic cell death pathways |
| 06/14/2000 | EP1007671A1 Fanconi-gen ii |
| 06/14/2000 | EP1007670A2 Two human g-protein coupled receptors: ebv-induced gpcr 2 (ebi-2) and edg-1-like gpcr |